Transgenic Overexpression of IL-37 Protects Against Atherosclerosis and Strengthens Plaque Stability

Conclusion: IL-37 may be a novel potential therapeutic target in patients with atherosclerotic heart disease.Cell Physiol Biochem 2018;45:1034 –1050
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research